Maladies hémorragiques congénitales : quel avenir pour les dérivés plasmatiques par rapport aux recombinants et aux produits sanguins labiles ?
Author:
Publisher
Elsevier BV
Subject
Biochemistry, medical,Clinical Biochemistry,Hematology
Reference16 articles.
1. Schved JF. Traitements de l’hémophilie. EMC Hématologie, Elsevier Masson SAS, Paris, 2008 [13-021-B20 937].
2. The risk of variant Creutzfeld-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products;Zaman;Haemophilia,2011
3. Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A;Goudemand;Blood,2006
4. Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A;Calvez;Blood,2014
5. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia;Mahlangu;Blood,2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3